In Brief
INTRODUCTION
The human skeleton is a composite of diverse tissue types including bone, cartilage, fat, fibroblasts, nerves, blood vessels, and hematopoietic cells. Each tissue type in the skeleton is generated and maintained by the precise regulation of distinct stem cells that possess the ability to replenish themselves and give rise to multiple, nonoverlapping cell-lineages. Among the most well-characterized stem cells in the skeleton is the hematopoietic stem cell (HSC), marked by a combination of cell-surface proteins and defined by its functional ability to form colonies in vitro and serially reconstitute long-term hematopoiesis in conditioned hosts (Baum et al., 1992; Spangrude et al., 1988) . Similarly, a significant amount of effort has been devoted toward identifying the cellular origins of the non-hematopoietic lineages in skeletal tissue, such as bone, cartilage, vascular endothelium, and stroma (Chan et al., 2015b; Marecic et al., 2015; Mé ndez-Ferrer et al., 2010; Worthley et al., 2015; Zhou et al., 2014) . However, the absence of reliable cell-surface markers, tissue dissociation protocols, and functional stemness assays has hampered the discovery of putative stem cells in the human skeleton.
Early efforts to isolate non-hematopoietic stem cells in the bone relied on the ability of bone marrow cells to adhere to plastic plates. However, these cultures of ''mesenchymal stem cells'' contain heterogeneous mixtures of cells with indeterminate potencies and promiscuous contribution to many overlapping lineages, such as bone, cartilage, fat, muscle, fibroblast, endothelial cells, and stroma. Likely, these cells represent a population comprised of multiple types of distinct stem cells rather than a uniform purified skeletal stem cell (SSC). Identification of several specific cell-surface proteins has improved the enrichment for skeletogenic activity in mesenchymal cultures (Lv et al., 2014) . THY1 (CD90), ENG (CD105), NT5E (CD73), and CD44 broadly label bone marrow stromal cells with variable colony-formation ability and differentiation to osteo-, chondro-, and adipo-lineages (Lange et al., 2005) . NGFR (CD271) and MCAM (CD146) additionally select for cells with higher colony-formation ability and multilineage differentiation (Quirici et al., 2002; Sorrentino et al., 2008) . CD146 + cells can also recreate a hematopoiesis-supportive hu- Yellow, bone; blue, cartilage; purple, marrow. Diagram of morphologically distinct zones in the growth plate of 17-week-old human fetal bone. P, proliferative zone; p-H, pre-hypertrophic zone; H, hypertrophic zone; D, diaphyseal zone (right). Scale bar, 100 mm.
(legend continued on next page)
STRO-1 and STRO-3 are expressed in cells capable of supporting human hematopoietic stem cells for an extended time in the presence of serum (Bensidhoum et al., 2004; Simmons and TorokStorb, 1991) . Still, cells expressing these markers are heterogeneous in their function, and the true nature of a functional human skeletal stem cell (hSSC) hierarchy in the bone marrow is missing. Our and others' evidence from lineage-tracing and clonal analysis in mice supports the existence of mouse SSCs (mSSCs) that exclusively give rise to bone, cartilage, and stroma, but not fat, muscle, fibroblasts, or hematopoietic tissue (Chan et al., 2015b; Marecic et al., 2015; Worthley et al., 2015) . We hypothesized that similar SSCs may exist in humans. In this study, we report the isolation of a human SSC (hSSC) capable of self-renewal and multilineage differentiation to bone, cartilage, and stroma. We demonstrate that these cells can be isolated from various human tissue sources and quantify their response to fracture. Crossspecies comparison of hSSCs with our mSSCs additionally provides insights into convergent and divergent skeletal evolution.
RESULTS

Single-Cell Transcriptome Analysis of Growth Plate and Diaphysis Reveals Markers for hSSC Isolation
As described above, our findings in mice (Chan et al., 2015b; Marecic et al., 2015) suggested that similar types of lineally related skeletal stem and progenitor cells may also be prospectively isolated by fluorescence-activated cell sorting (FACS) from human skeletal tissue. We reported a high frequency of clonal mSSC-derived cell expansion in the growth plate of the mouse bone by lineage-tracing using Actin-Cre ER x Rainbow mice (Chan et al., 2015b) . Therefore, we performed single-cell RNA sequencing (scRNA-seq) of the growth plate and diaphysis of a 17-week human fetal femur to identify individual cells with the greatest homology in terms of gene expression to the mSSC and the mouse bone, cartilage, stromal progenitor (mBCSP), which is immediately downstream of the mSSCs in the differentiation hierarchy ( Figures 1 and 4 , right panel) (Chan et al., 2013 (Chan et al., , 2015b Fleming et al., 2015) . We first microdissected the fetal bone into seven regions based on morphological differences exhibited by the cells in each region after Movat's pentachrome (MP) staining (Figures 1A and 1B) and intravital staining with Hoechst and Calcein-AM ( Figure 1C ). These regions consisted of the two halves of the proliferative zone (P1 and P2), two halves of the pre-hypertrophic zone (p-H1 and p-H2), two halves of the hypertrophic zone (H1 and H2), and the single diaphyseal zone (D) ( Figure 1C ). We then mechanically and enzymatically dissociated these tissue regions separately into single-cell suspensions and sorted non-hematopoietic (CD45 À CD235a À ) cells from each region into 96-well plates for scRNA-seq using Smart-seq2 (Figures 1D and 1E) (Picelli et al., 2014) . To query our scRNA-seq data and identify rare cells with stem cell-like mRNA expression, we used the Gene Expression Commons (GEXC) (Seita et al., 2012) to search for genes specifically expressed in mSSCs and mBCSPs (Chan et al., 2015b) , but not their downstream progeny, and created a gene set of 76 mSSC/mBCSP-specific genes and their human orthologs (Table S1 ). We then calculated the percentage of transcriptionally active human orthologs to mSSC/ mBCSP-specific genes for each sequenced single cell in each region. In contrast to all other regions of the bone, the cells within the second half of the pre-hypertrophic zone (p-H2) and the first half of the hypertrophic zone of the growth plate (H1) showed significantly higher expression of human orthologs to mSSC/ mBCSP-specific genes (Figures 1F and S1A) . A comparative analysis of the most variable cell-surface proteins across the different regions, particularly those that were significantly enriched or depleted within the hypertrophic zone (H1) of the growth plate compared to the diaphysis (D) , unveiled a list of candidate markers that could provide a basis for antibody-mediated isolation of human growth plate cells by FACS ( Figure S1B ). Through flow-cytometric analysis of those candidate cellsurface markers against which antibodies were available, we identified a panel including PTPRC (CD45), GYPA (CD235a), TEK (TIE2), PECAM1 (CD31), PDPN, MCAM (CD146), NT5E (CD73), CD164, and THY1 (CD90) that separate growth plate zone cells into distinct subpopulations (Figure S1C ). Immunofluorescent (IF) staining against PDPN, CD146, CD73, and CD164 confirmed heterogeneity in the expression of these markers among the cells within the growth plate and the diaphysis. PDPN was primarily expressed in the growth plate and hypertrophic zone (pH2, H1/H2), while CD146 was mainly expressed in the diaphyseal zone (D) (Figure S1D, middle panel) . In addition, a PDPN + CD146
+ cell population was also present in the growth plate (p-H2, H1/H2) (Figure S1D, middle panel) . CD73 and CD164 were both enriched in the growth plate (p-H2, H1/H2) and further divided cells from this region into subpopulations based on the presence or absence of these two cell-surface markers (Figure S1D, right panel) . Revisiting the scRNA-seq data, we found that PDPN, NT5E, and CD164 transcripts were enriched, and MCAM transcripts were depleted in the p-H2/H1 zones of the growth plate-a region with high homology to the mSSC/mBCSP in terms of mRNA expression. This contrasted with the regions that showed low homology to the mSSC/ mBCSP, such as the diaphysis (D) (Figures 1F, S1E , and S1F). Moreover, by grouping cells based on expression of specific genes, we observed that PDPN
NT5E
+ CD164 + single cells were enriched in the growth plate (p-H2, H1/H2), depleted (C) Whole tissue stain of a viable 17-week-old human fetal femur with Hoechst and Calcein-AM intravital dyes (top; scale bar, 5 mm) revealing morphologically distinct regions (bottom; scale bar, 500 mm) corresponding to the six growth plate zones (P1, P2, p-H1, p-H2, H1, and H2) and the diaphyseal zone (D) . (D) Experimental strategy for identifying human SSCs using scRNA-seq and a database of conserved SSC-specific genes. (E) Heatmap of most variable genes detected by scRNA-seq analysis of cells isolated from dissected human growth plate zones as shown in (C) . (F) Bar chart showing percent of human orthologs to mSSC/mBCSP-specific genes expressed in human CD45 À CD235a À single cells for each zone described in (C) . Red trendline shows percent enrichment. Statistical significance for zones with highest enrichment for human orthologs to mSSC/BCSP-specific genes was calculated by one-way ANOVA with post hoc Tukey HSD test with proliferative 1 (P1) as reference at an a-level of 0.01 (left). **p value < 0.005, ****p value < 0.0005; ns, not significant. Average transcripts per million (TPM) for five surface markers identified by scRNA-seq-enrichment-screen followed by empirical testing by FACS: PDPN, CD146 (MCAM), CD73 (NT5E), CD164, and THY1 (CD90) (right). n = 4. See also Figure S1 and Tables S1 and S2. in the diaphysis (D) , and comprised a larger percentage of the cells that showed high degree of homology to mSSC/mBCSP (Figure S1E 
CD73
À CD164 À population-hereafter collectively referred to as the human chondroprogenitors (hCPs) (Figures 2C, and 2E ).
Immunostaining with human nuclear antigen confirmed that human skeletal progenitor-derived ossicles in the renal capsule were indeed of human origin ( Figures 2D and S2B had undergone multiple cycles of division as evidenced by logfold reduced DiD-label on flow cytometry ( Figure S2B ). We then sorted DiD lo cells from the primary graft for an in vitro serial colony formation assay and a serial transplantation assay under the renal capsule of a secondary NSG mouse as above (Figure S2A) . Sorted DiD lo cells from the primary graft were capable of at least two rounds of successive (tertiary) colony formation and exhibited similar morphology and distribution of contituent cells as control cells that were freshly sorted from fetal growth plates ( Figure S2C ). Secondary renal capsule grafts were explanted 4 weeks after transplant, grossly examined by imaging, and stained with MP. The secondary ossicle was comparable to the ossicle generated after primary transplant ( Figure S2D ) and revealed regions of Alcian blue-labeled cartilage and Saffron yellow-labeled bone by MP staining (Figure S2E 
Determination of Human Skeletal Lineage Hierarchy
To determine whether individual chondrogenic, osteogenic, and the multipotent skeletogenic populations are lineally related or whether they each represent independent, self-renewing stem and progenitor fractions, we evaluated the capacity of the seven flow-sorted skeletal populations (see above) to differentiate into other subsets in vitro and in vivo. We cultured each of the purified cell populations in serum-rich base media. At weekly intervals, adherent cells were lifted from the culture dish by collagenase digestion and then analyzed by FACS ( Figure 3A Figure 3B ). Alizarin Red S staining showed that these putative-hSSC-derived cells comprised distinct osteogenic and non-osteogenic cells ( Figure 3C ). We also measured the adipogenic differentiation potential of the sorted putative hSSCs by either subjecting them to in vitro differentiation or by analyzing the ossicles formed after transplanting them in RFP-mice and did not observe any evidence of adipogenesis by either fetal or adult bone marrow-derived cell subsets ( Figure S3 ). To validate our in vitro results, we transplanted 100,000 freshly isolated putative hSSCs under the renal capsule of immunodeficient NSG mice. We isolated the grafts 4 weeks after transplant and analyzed the cell suspension derived from the graft by FACS. As seen in vitro, the putative hSSCs gave rise to the other skeletal subsets after transplant ( Figure 3D ).
To demonstrate in situ clonal contribution to multiple skeletal lineages, we labeled the putative hSSCs randomly with multiple distinct fluorescent proteins (RFP, EGFP, and CFP) using lentiviral transduction prior to transplant under the mouse renal capsule (Weber et al., 2011) . We found that clonally marked putative hSSCs generated both cartilage and bone staining regions in the subcapsular ossicles ( Figures 3E and S2E ). Collectively, these data show that the putative hSSC fraction (PDPN
is enriched in hSSCs that are capable of lineal generation of chondrogenic and osteogenic subsets and are at the top of the skeletogenic differentiation tree ( Figure 3F ). See also Figure S2 and Table S2 . (C) Alizarin Red S staining of individual human skeletal progenitor subsets to measure osteogenicity ( [i] hSSC, human skeletal stem cell; [ii] hBCSP, human bone, cartilage, and stromal progenitor cell; [iii] hOP, human osteogenic progenitor; [iv] hCP, human chondrogenic progenitor 5-day-old immunodeficient NSG mice ( Figure 4B ). The human fetal phalanges efficiently engraft and develop into growing bones on the flank of a mouse ( Figure 4B ). The phalangeal grafts grew much larger in size than recipient host mouse limbs. Moreover, we found that localized injury induced by unicortical fractures on the xenografted phalangeal bones resulted in significant localized expansion of hSSCs relative to unfractured areas in the same bone ( Figures 4C and 4D , lower panel). Therefore, consistent with the fracture-induced expansion of mSSCs in mice (Marecic et al., 2015) , the injury-induced hSSC (PDPN hSSCs Generate Hematopoiesis-Supportive Stroma As observed with mSSCs (Chan et al., 2009 (Chan et al., , 2013 (Baum et al., 1992) were co-cultured with hSSCs, hBCSPs, hOPs, or no stroma in serum-free conditions supplemented with stem cell factor (SCF) and thrombopoietin (TPO). After 14 days of co-culture, the cells were lifted with EDTA and transplanted into recipient immunodeficient NSG mice that were conditioned using sublethal irradiation as shown earlier (Reinisch et al., 2015) . Freshly isolated cord-blood hHSCs were also transplanted as a positive control. Eight weeks after transplant, bone marrow aspirates were collected from recipient mice and Human fetal phalanges from 18-week-old fetuses were transplanted subcutaneously under the dorsum of day 5 NSG mouse pups. Fractures were introduced at 4 weeks post-transplantation (middle left and right panels) within the engrafted human phalanx (PP, proximal phalanx; MP, middle phalanx; DP, distal phalanx; defect indicated by black circle in MP region). After a further 2 weeks post-injury the phalanges were explanted for analysis (n = 12). For both uninjured and injured samples, explants were digested, hSSC were purified by FACS, plated, differentiated for 2 weeks, and then stained using Alizarin Red (bottom). (C) Comparison of uninjured (left) and injured (right) human xenografts. Each panel shows the corresponding FACS plots with gating strategy to isolate hBCSPs and hSSCs (top). Purified hBCSPs and hSSCs were plated, differentiated for 2 weeks, and stained using Alizarin Red (bottom). Scale bar, 100 mm. (D) Boxplots showing the effect of injury on the hSSC populations in both the primary human samples (top) (uninjured, n = 3; injured, n = 10) and the human xenograft model (n = 12) (bottom). Error bars represent SE. *p < 0.05, **p < 0.01. See also Table S2 .
analyzed for the presence of human hematopoietic reconstitution ( Figure S4A ). While there was little engraftment from transplants of hHSCs cultured without stroma, all hHSCs cocultured with skeletal progenitor populations gave rise to some levels of engraftment. hHSCs co-cultured with hBCSPs generated the highest level of multilineage myeloid and lymphoid engraftment ( Figures S4B and S4C ). We found that hSSCs and hSSC-derived subsets, express a variety of potential hematopoiesis-supportive cytokines with matching cognate receptors expressed on hHSCs and downstream hematopoietic progenitors, including ANGPT1, CSF1, SDF, IL27, IL7, and SCF ( Figures S4D-S4G ). Consistently, we also found that hHSCs express a variety of factors that could have a potential role in supporting the hSSC lineage, including BMP2, BMP8A, DHH, FGF3, WNT1, and WNT8 ( Figure S4Fi ), supporting a model of stem-cell crosstalk within the bone marrow.
hSSCs from Other Skeletal Tissue Sources We had observed in mice that mSSCs in fetal, newborn, and adults have similar surface marker profiles (Chan et al., 2015b) , suggesting that hSSCs may also be present in a variety of different skeletal tissues and may be isolated by the same set of surface markers. Indeed, we found that cells isolated from freshly resected adult human femoral head specimens also contain significant populations of non-hematopoietic, non- . We previously observed that high concentrations of BMP2 trigger skeletal reprogramming of adipose stromal cells in mice (Chan et al., 2015b; Lo et al., 2012 ). Therefore, we tested whether subcutaneous injection of human adipose stroma with high levels of recombinant BMP2 in Matrigel can give rise to heterotopic ossicles enriched for PDPN Single-Cell Transcriptomic Comparison of Fetal-, Adult-, B-HAS-, and iPSC-Derived hSSCs We observed differences in the skeletogenic potential of hSSCs isolated from fetal, adult, B-HAS, and iPSC tissues ( Figure 5D ). For example, fetal and iPSC-derived SSCs have a higher tendency to form cartilage than adult SSCs. To investigate these phenotypic differences between the various sources of hSSCs, we compared single hSSCs from fetal, adult, B-HAS, and iPSC-derived tissues using scRNA-seq ( Figure 6A ). Principal component analysis (PCA) of 42 fetal, 36 adult, 77 B-HASderived, and 41 iPSC-derived hSSCs demonstrates that hSSCs isolated from different sources cluster together ( Figure 6B ). However, the second principal component (PC2) separates a few iPSC-derived hSSCs from this cluster as outliers. The gene loadings that most contribute to PC2 include important early skeletogenic factors such as SPARC, COL1A1, SFRP2, LUM, and FOS ( Figure 6B )-suggesting that the outliers may comprise hSSC precursors or poorly differentiated cells during skeletal induction of iPSCs. To specifically study single hSSCs from a skeletal and developmental perspective, we curated a set of signaling pathways and bone development genes from the GEXC and the Molecular Signatures Database (Table S3 ) (Liberzon et al., 2015; Seita et al., 2012) . Using these 296 genes, we performed supervised hierarchical clustering of 196 single hSSCs and identified ten gene clusters (Figure 6C, (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Five clusters demonstrate transcriptional similarity in expression of key skeletogenic genes, including SPARC, COL1A1, ITGB1BP1, and RHOA (Figure 6C, (1) (2) (3) (4) 9) . Four clusters recapitulate the phenotypic similarity of adult to B-HAS-derived hSSCs, and fetal to iPSC-derived hSSCs based on key genes such as OSR2, SPG20, FOS, and WLS (Figure 6C, 5, 6, 8, 10) . The last cluster captures transcriptional differences in expression levels between primary isolates and in vitroderived hSSCs based on genes such as TCF7L2, FST, and CHRDL1 (Figure 6C, 7) . To assess the degree of similarity between individual hSSCs and groups of hSSCs, we calculated the Pearson correlation coefficients for each pair of single and groups of hSCCs (Figures 6D and 6E) . When analyzed separately, we found that adult hSSCs were more heterogeneous compared to fetal, B-HAS-derived, or iPSC-derived hSSCs. The greater degree of heterogeneity among adult hSSCs may be a result of diverse specialization within the stem cell pool with age ( Figure 6D ). Upon aggregating cells within each group, we found that fetal hSSCs most closely correlated with iPSC-derived hSSCs and B-HAS-derived hSSCs most closely correlated with adult hSSCs. When we removed the iPSC-derived hSSCs from the comparison, we found that fetal hSSCs correlated more with adult hSSCs than with B-HAS-derived hSSCs ( Figure 6E ). The correlation data ( Figure 6E ) is largely consistent with our functional data ( Figure 5D ) except for B-HAS-and iPSC-derived hSSCs, both of which are functionally similar with respect to their differentiation potential but are less similar by single-cell mRNA expression. Table S2 .
Convergent and Divergent Skeletal Regulatory Programs between Mouse and Human SSCs
Humans and mice diversified from a common ancestor nearly 100 million years ago (Nei and Glazko, 2002) . While many aspects of their physiology are similar, mouse and humans also differ in several ways related to their skeletal systems. We observe that sub-renally transplanted human fetal bones grow dramatically larger after 2 months of growth compared to their mouse counterparts ( Figure 7A ). In addition, hSSCs produce up to 100-fold larger CFUs compared to mSSCs ( Figure 7B ). These results suggest some aspects of skeletal size control are cell intrinsic and could reflect differences in genetic and epigenetic regulation at the level of individual SSCs.
To address this, we purified human and mouse fetal SSCs at similar developmental stages (e17.5 mouse and 19-week-old human fetal bones) for a comparative gene expression analysis by microarray. We normalized expression values using the GEXC (Seita et al., 2012) that assigns a threshold value to each probeset using StepMiner (Sahoo et al., 2007) and calculates a percentile value between À100% and +100% for each available gene, allowing us to compare mouse and human gene expression on a normalized, continuous scale. Focusing specifically on signaling pathways and genes associated with bone B   P3H1  CSNK2B  SBDS  SDC2  DAB2  ITGB1BP1  ANXA4  PLS3  CTNNB1  GLG1  UBA52  FGFR1  SHC1  CDC42  FBN1  CD44  CAV1  DNAJB6  TGFB1I1  PPP1CA  PLAUR  SNAI2  MDK  FGF7  EGR1   SPARC  ANXA2  PPIB  UBC  UBB  RPS19  RHOA  COL1A1  HTRA1   FOS   THBS3  RARG  IGF1  NBL1  GAS1  SULF2  OSR2  SFRP4  COMP   MEIS1  NDRG2  PIK3R1  TCF7L2  ACVR2A  FST  CHRDL1  CPZ  JUN  KLF4  HES1  NR4A2  GPC3  TGFB3  LRRC17  SOX9  BMPR1A  BMPR2  RUNX2   DHRS3  DKK3  PLAU  PLPP3  ENG  GALNT11  WASF2  CTNND1  RAB14  FKBP8  NOTCH2NL  MESDC2  TGFBR2  FOXP1  TBL1XR1  SOX4  PTEN  AES  UBE2B  RBPJ  PIP4K2A  DDB1  TOB1  TWSG1  NCSTN  WDR61   CFD  HTRA3  SFRP2   SNW1  FERMT2  RAB5A  INSIG1  PSENEN  MAPK1  PAPSS2  ABI1  WLS  DDIT3  CSNK1A1  SPG20  HBP1   CTGF  CYR61   TAX1BP3  ILK  GNAS  RPS27A  VKORC1  SERPINH1 (Table S3) in single fetal (n = 42), adult (n = 36), B-HAS-derived (n = 77), and iPSC-derived hSSCs (n = 41). The heatmap is grouped into 10 clusters obtained based on the expression patterns of the selected genes using Ward's method. (D) Pearson correlation matrix showing similarities between single fetal, adult, B-HAS-derived, and iPSC-derived hSSCs based on gene expression values as in (B) . Scale shows color gradient for R 2 value from 0 to 1.
(E) Pearson correlation matrix with numerical coefficients showing degree of similarity between aggregate fetal, adult, B-HAS-derived, and iPSC-derived hSSC populations. Mean log 2 (TPM+1) was calculated separately for each group by calculating the sum of the log 2 (TPM+1) values for each gene in (B) and dividing the sum by the total number of cells in each group. See also Table S2. development (Table S3) , a pairwise comparison between fetal e17.5 mSSC and 19-week fetal hSSC revealed that over 66.5% of transcription within the selected signaling pathways and bone development genes are expressed in both mSSCs and hSSCs. We analyzed the genes that constitute the WNT, BMP, Hedgehog, FGF, and Notch pathways as well as additional genes that constitute the gene ontology (GO) gene set for bone development. As expected, a few active genes in mSSCs were turned off in hSSCs, while other genes that were not expressed in mSSCs were found to be active in hSSCs (Figures 7C and S5) . Notable among divergent genes are key members of the WNT signaling pathways, SOST, CXXC4, and DNAJB6, all of which have been implicated earlier in human bone development but are not expressed in mSSCs ( Figure 7C ) (Kojima et al., 2009; Menezes et al., 2012; Moester et al., 2010) . Among the genes that are expressed by both mouse and human SSCs, we found some well-known master transcriptional regulators of skeletogenesis, including RUNX2, SOX9 ( Figure 7C )-in addition to some lesser known transcription factors (TFs) such as OSR2 and TWIST1 (Table S3) .
To better understand epigenetic regulation of skeletal development, we performed ATAC-seq on mouse and human SSCs isolated from bones at similar developmental stages (18-week-old human fetal bone and e17.5 mouse fetal bone) (A) Renal capsule transplant of e14.5 mouse bones at day 0 (top left) and 10-week human fetal bones at day 0 (bottom left) in NSG mice. Images highlighting the resulting difference in size between the mouse (top middle) and human (bottom middle) bones after 2 months of growth in vivo. Scale bar, 5 mm; n = 3. Pixels corresponding to the bone tissue in the images were measured and normalized to their respective pixel-counts at day 0 to calculate growth ratios, which are represented as bar chart (right). Error bars represent SD; *p < 0.05. (B) Brightfield image of CFUs (red dashed line) that were formed after 2 weeks of culture of either e14.5 fetal mSSCs (top) or 10-week fetal hSSCs (bottom) highlighting the difference in their sizes. Scale bar, 1 mm. Bar chart showing the average number of cells per hSSC-derived and mSSC-derived colonies (right). Error bars, SD; **p < 0.01; n = 5. (C) Table listing shared and unshared representative genes and their expression trends ([ = upregulated, Y = downregulated) between mouse and human focusing specifically on major signaling pathways and gene ontology (GO) gene set for bone development based on comparative microarray analysis of mSSCs (e17.5) and hSSCs (19-week) using the GEXC (n = 3). (D) UCSC genome browser track showing the ATAC-seq signal at the SOST locus in 18-week fetal hSSCs (top). Regions within four ATAC-seq peaks that contain RUNX-binding motifs are magnified. Mammalian conservation track from UCSC genome browser is shown for human, rhesus, mouse, dog, and elephant. RUNX2-binding motif (forward or reverse) found at each site is also shown (middle). Genome browser track showing ATAC-seq signal at the mouse Sost locus in e17.5 fetal mSSCs (bottom). See also Figures S5, S6 , and S7 and Tables S2, S4, and S5. as above to identify sites of accessible chromatin. This analysis revealed various open chromatin-sites comprising active promoters as well as gene-distal enhancers that are conserved between mouse and human ( Figure S6 ). To drill-down to the species-specific epigenetic differences, we focused our analysis on genes that are expressed in the hSSC but not in the mSSC (see above). For these gene-loci, we found that in human (but not always in mouse), the accessible open chromatin sites were enriched in TF-binding-motifs recognized by the core SSC-specific-TFs that are conserved between human and mouse in terms of their expression. For example, even though RUNX2 is expressed in both human and mouse SSCs (Figure 7C ), the predicted RUNX2 binding-sites are enriched in the open chromatin landscape of human SOST but not mouse Sost locus and therefore, SOST is expressed only in hSSCs but not mSSCs ( Figure 7D ). The same is true for another human-specific gene, DNAJB6 ( Figure S6I ). Interestingly, overexpression of either human SOST or DNAJB6-both of which are inhibitors of WNT signaling-by lentiviral transduction in mSSCs led to significantly larger subrenal ossicle formation relative to GFP virus control ( Figures S7A-S7E ). This is also consistent with the delayed osteogenesis in SOST or DNAJB6 transduced mSSCderived ossicles-as exemplified by the reduced bone staining (yellow) and enhanced cartilage staining (blue) of cross-sections of the ossicles harvested 16-days after transplant (Figures S7Civ, lower panel, and S7Div, lower panel) . These data suggest that functional genes that are expressed in a species-specific manner may be a result of divergent evolution of epigenetic regulation.
Genome-wide association studies (GWAS) have identified several non-coding genomic polymorphisms that are associated with skeletal traits in humans such as bone mineral density and height Estrada et al., 2012) . We analyzed 56 such single nucleotide polymorphisms (SNPs) that are strongly associated with variation in bone mineral density in humans and found that one of the SNPs changes the predicted RUNX binding site within the SOST locus ( Figure 7D ) while another was within the accessible non-coding regions surrounding the WNT4 promoter ( Figure S6J ). These observations further exemplify the key role played by the SSC-specific genes both during development and homeostasis.
DISCUSSION
Our data support a developmental hierarchy of skeletal progenitors in humans organized by cells with differential expression of PDPN, CD146, CD73, and CD164. We find that a purified population of PDPN + CD146 À CD73 + CD164 + cells serially generate CFUs from single cells in vitro and multilineage ossicles containing bone, cartilage, and stroma upon subrenal transplantation in mouse. Notably, these stem cells do not differentiate into adipocytes, suggesting that adipocytes may be replenished by other sources of resident bone marrow stem cells. Instead, hSSCs lineally transition into an early bone, cartilage, and stroma progenitor (hBCSP), which then give rise to osteoprogenitors (hOPs) and chondroprogenitors (hCPs) prior to terminally differentiating into bone, cartilage, and stroma.
hSSCs from Different Skeletal Sources Are Similar but Distinct We show that hSSCs and their downstream progeny can also be isolated from skeletally differentiated iPSCs and B-HAS. When compared to fetal and adult hSSCs, we observe that there is variation in the proportion of cartilage and bone in the ossicles from different hSSC sources, which correlates to gene expression differences between individual hSSCs as quantified by scRNA-seq. The gene sets that segregate different hSSC populations provide molecular landmarks for modifying skeletogenic conditions to endow B-HAS-or iPSC-derived hSSCs with enhanced self-renewal or increased chondrogenic and/or osteogenic activity.
A Molecular Glimpse of Skeletal Speciation
Finally, we compared mouse and human SSCs to gain insight into the evolutionary basis of stem cell-mediated skeletogenesis. We found that when equally sized human and mouse fetal bones were transplanted in mice, the human fetal bones far outgrew their mouse counterparts. Similarly, after equal time in culture, CFUs from hSSCs had over 100-fold more cells than CFUs from mSSCs. These initial observations along with molecular comparisons of SSCs from mouse and humans using microarray, and ATAC-seq analysis led us to suspect that there are intrinsic mechanisms that regulate skeletogenesis and that molecular comparison of mouse and human SSCs could explain divergences in skeletal phenotype.
Overexpression of two genes (SOST and DNAJB6) in mSSCs that are expressed in hSSCs but not mSSCs, lead to significantly larger mSSC-derived ossicles, suggesting that SOST and DNAJB6 expression in hSSCs may be important for skeletal size control at the stem cell level. This was unexpected as SOST is a known negative regulator of WNT signaling and bone formation in osteoblasts (Compton and Lee, 2014) . We hypothesize that expression of SOST by hSSC could be important for extending hSSC activity during fetal development, perhaps by delaying premature WNT-dependent osteoblast differentiation and/or osteoblast-mediated feedback signaling.
Our analysis also revealed differential expression of various genes involved in the synthesis of connective proteins (Tables  S4 and S5 ), such as types of collagen that could underscore differences in biomechanical properties between mouse and human skeletal tissues. With the identification of the SSC in both mouse and human, and the delineation of their downstream skeletal lineages, we provide a cell atlas to enable a series of new investigations into the genetic and molecular determinants of skeletal formation and development. Moreover, given the tremendous medical burden imposed by degenerative, neoplastic, post-traumatic and post-surgical skeletal disorders, we believe that identifying the hSSC and elucidating its lineage map will enable the molecular diagnosis and treatment of skeletal diseases (Beyth et al., 2011) . Using this approach, we recently showed that even complex skeletal pathologies that arise from systemic diseases like diabetes can be precisely diagnosed and remedied by comparing the molecular phenotype of normal and diseased SSCs (Tevlin et al., 2017) . Therefore, we anticipate that further characterization of the hSSC, and the ontogeny of hSSC-derived skeletal progenitors as described here will facilitate the development of patient-specific approaches to diagnosing and reversing diverse types of skeletal disorders.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice BA mice (C57BL/Ka-Thy1.1-CD45.1), purchased from the Jackson laboratories (Mouse strain datasheet JAX:000406), and used for isolation of mouse SSC and skeletal progenitors for gene expression and ATAC-sequencing experiments as described below. NSG (NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ, JAX: 005557) immunodeficient mouse strains were used to establishing the human xenograft model and as recipients for either subcutaneous or renal capsule transplantation of human skeletal and hematopoietic stem and progenitor cells. RFP (B6.Cg-Tg(CAG-mRFP1)1F1Hadj/J, JAX: 005884) mice were used for hSSC and HAS/B-HAS transplantation to assess adipogenic potential in vivo. All mice were male and 8-12-weeks-old unless otherwise stated in the results section. Animals were maintained at Stanford University animal core facility in accordance with Stanford and National Institutes of Health guidelines.
We do not have any information regarding the sex of fetal or cord blood specimens utilized during this study. The gestation ages of fetal specimens are listed in Table S2 and described in the respective results sections. Human adipose stroma (HAS) were obtained from female patients ranging from 30-50 years old for both in vitro and in vivo adipogenesis experiments as well as skeletal induction and scRNA-seq experiments. Adult hSSCs, and corresponding lineage populations, were obtained from femoral head bone marrow from a 58-year old male, a 71-year old female, and a 58-year-old female donor. Age and sex of donors that contributed fractured bone specimens is listed in Table S2 . The IPSC line, SCVI 113, used in this study was derived from peripheral blood monocytes of a 51-year-old male. We do not have age or sex information regarding primary cells used in the chondrogenic differentiation studies.
Fetal and adult human samples
Fourteen human fetal samples were obtained from Stemexpress (Folsom, CA) and shipped overnight. Samples ranged in age from 10 to 20 weeks of gestation with no restrictions on race or gender. Fetal sample procurement and handling was in accordance with the guidelines set by the Institutional Review Board (IRB-35711). 22 adult femoral heads (58-74 years old), 3 uninjured human bones (16-30 years old), and 10 fractured long bone specimens (20-90 years old) were obtained from Stanford Hospital in accordance with guidelines set by the Institutional Review Board (IRB-35711). On this IRB, informed consent was not required as samples were considered biological waste. No restrictions were made regarding the race, gender, or age of the specimen's donor. Following excision, all femoral head specimens were placed on ice, and skeletal stem and progenitor cells were isolated from the bone marrow cavity and articular cartilage, as described below. Adipose stromal cells were harvested from lipoaspirate human tissue (n = 5) from female donors, 30-50 years old. Informed consent was obtained in all cases, and samples were obtained from Stanford Hospital in accordance with guidelines set by the Institutional Review Board (IRB-25954). Human core-blood samples were obtained according to the Administrative Panel on Human Subjects Research Institutional Review Board (IRB)-approved protocols (Stanford IRB no. 18329, no. 6453, and no. 5637 ) with informed consent. Cord blood was collected with written informed consent from the mother, which was obtained before delivery of full-term pregnancies at the Lucile Packard Children's Hospital, according to IRB-approved protocols (Stanford IRB no. 5637) or purchased from the New York Blood Center (NYBC). All cord-blood samples were processed within 24 h after delivery and used fresh.
Cell lines
Human monocyte derived induced Pluripotent Stem Cell (iPSC) line, SCVI 113, was a kind gift from the laboratory of Joseph C. Wu (joewu@stanford.edu). Donor was male 51-year-old.
Bacteria and Virus strains
Lentivirus expressing GFP, RFP, and CFP were subcloned in the Weissman laboratory from pLL3.7 deposited in Addgene (https://www.addgene.org/11795/). Validated lentiviral expression plasmids containing cDNA expression cassettes for SOST (Cat#Mm11378) and DNAJB6 (Cat#Mm21356) were acquired from Genecopeia.
METHOD DETAILS Human Fetal and Adult Bone dissociation
Human fetal long bones were separated, gently denuded of soft tissue with paper towels, and dissected for the growth plate and its constitutive zones. The distinct areas of the growth plate were distinguished based on differences in the size and shape of the chondrocytes and osteoblasts that are representative of each growth plate zones. These differences can be (Figures 1B and 1C) . The proliferative zone (P) is identified by the relatively small size of the chondrocytes, the pre-hypertrophic zone chondrocytes (p-H) are medium-sized, and the hypertrophic chondrocytes (H) are among some of the largest chondrogenic cells in the growth plate. Finally, the diaphyseal region (D) includes trabecular bone and marrow. For scRNA-seq analysis, we further split each of the chondrocyte zones (P, p-H, and H) into equivalently sized halves (1 & 2)-thus, a total of 7 distinct regions were used for analysis including the diaphyseal zone.
From adult human femoral head specimens, the articular cartilage was dissected out with scalpels and the bone marrow was scraped out with a spatula from the marrow cavity. The marrow and the cartilage tissue were then minced separately with razor blades, resuspended in 3000 U/mL type II collagenase (Sigma-Aldrich, Cat#C6885) digestion buffer supplemented with 100 U/mL DNase I (Worthington, Cat#NC9199796) and incubated at 37 C for 40 min under constant agitation. The supernatant was filtered through a 70 mm nylon mesh and quenched with staining media (2% fetal bovine serum (FBS), in phosphate-buffered saline (PBS), GIBCO, Cat#C14190500BT). Digestion was repeated twice more prior to centrifugation at 200 g at 4 C followed by resuspension in staining media.
Fluorescence-activated cell sorting (FACS)
Human skeletal cells were separated from red blood cells (RBCs) and bone dust by density gradient separation using 1:1 Histopaque of density 1.119 g/mL (Sigma-Aldrich, Cat#11191). The buffy coat was collected, washed with staining media, and the resulting cell suspension was depleted of CD45+ cells by magnetic-activated cell sorting (MACS) (Miltenyi, . Cells were blocked with mouse IgG and stained with fluorochrome-conjugated antibodies against CD45 (BioLegend, Cat#304029-BL), CD235a (BioLegend, Cat#306612-BL), CD31 (Thermo Fisher Scientific, Cat#13-0319-82), CD202b (Tie-2) (BioLegend, Cat#334204), CD146 (BioLegend, Cat#342010), PDPN (Thermo Fisher Scientific, Cat#17-9381-42), CD90 (THY1; BioLegend, Cat#328110), CD164 (BioLegend, Cat#324808), and CD73 (BioLegend, Cat#344016). Flow cytometry was performed on FACS Aria II (BD Biosciences). Gating schemes were established with fluorescence-minus-one (FMO: staining with all fluorophores except one) controls and negative propidium iodide (PI) (Sigma-Aldrich, Cat#P4170) staining (1 mg/ml) was used as a measure for cell viability.
In vivo transplantation of cells
SSCs or other skeletal cells were purified using FACS and resuspended in 2 mL of Matrigel (Corning, Cat#CB40234A) and then injected subcutaneously or underneath the renal capsule of 8-12-week-old immunodeficient NSG mice. Injected cells developed into a graft after 4 weeks. The grafts were surgically removed for analysis. For serial transplantation, SSCs from the graft were isolated by FACS, labeled with DiD lipophilic dye-AF647 (Cat#V22887), and > 1.5 million cells were transplanted under the renal capsule of 8-12-week-old NSG mice. Ossicles were explanted 2 weeks later for analysis.
In vivo transplantation of whole bones Fresh 10-week-old human fetal and e14.5 mouse fetal femurs were transplanted underneath the renal capsule of 8-12-week-old anesthetized immunodeficient NSG mice. Bones were incubated for 2 months prior to surgical excision and analysis of graft.
Human xenograft Model
Ten 18-week-old fetal phalanges (proximal, middle, and distal phalanges) were transplanted subcutaneously into postnatal day 5 NSG mouse pups. The pups reached skeletal maturity at 4 weeks and the xenograft was opened. Unicortical fractures were performed using a drill as shown in Figure 4B . The fractures were allowed to heal for 2 weeks and then harvested and dissociated as described above. Cells were analyzed by FACS and underwent osteogenic differentiation and Alizarin Red staining (Sigma-Aldrich, Cat#A5533) to assess osteogenic potential.
Immunofluorescence Immunofluorescence (IF) on cryopreserved ectopic bone specimens were performed using M.O.M. immunodetection kit (Vector Laboratories, Cat#BMK-2202) according to manufacturer's instructions. Briefly, specimens were treated with a blocking reagent 5%-2% donkey (Sigma-Aldrich Cat#D9663) or goat serum (Thermo Fisher Scientific, Cat#G9023) supplemented with 1% Bovine Serum Albumin (BSA; Sigma-Aldrich, Cat#A9647) in Tris Buffered Saline (TBS, Sigma-Aldrich, Cat#T5912), then probed with monoclonal primary antibody at 4 C overnight. Primary antibodies: CD164 (Sigma-Aldrich, Cat#HPA010636), Perilipin A (Chemicon, Cat#AB10200), Adiponectin (Invitrogen, Cat#MA1-054), Human Nuclear Antigen (Abcam, Cat#ab191181), Collagen II (Abcam, Cat#ab34712), Osteocalcin (Abcam, Cat#ab13418). Specimens were next washed with PBS, probed with secondary antibodies conjugated to Alexafluor-488 (AF488; Invitrogen, Cat#A11006) or AF647 (Invitrogen, Cat#A21236) as needed. Specimens were incubated with 1 ug/ml of DAPI (Biolegend, Cat#422801) for 10 mins and then washed twice. The specimens were then mounted with a coverslip using , and imaged with a Leica DMI6000B inverted microscope system. IF on tissue-cultured cell specimens were performed similarly to cryopreserved specimens. Briefly, cultured cells in 6-well to 96-well culture plates were washed with PBS and fixed in 2% paraformaldehyde (PFA, Electron Microscopy Sciences, Cat#15710) at 4 C overnight. Specimens were treated with a blocking reagent (see above), then probed with monoclonal antibody at 4 C overnight. Next, specimens were washed with PBS, probed with secondary antibodies conjugated to Alexafluor-488 (AF488; Invitrogen, Cat#A11006) or AF647 (Invitrogen, Cat#A21236) as needed, washed, immersed in PBS, and imaged with a Leica DMI6000B inverted microscope system (LAS X software, Leica Microsystems). Monoclonal antibodies: human Collagen II (Abcam, Cat#ab34712), Osteocalcin (Abcam, Cat#ab13418), AF-conjugated secondary antibodies (AF455; Molecular Probes Cat#A11034, and AF647; Molecular Probes, Cat#A31573).
In vivo skeletal-induction with local factors Adipose stromal cells were harvested from lipoaspirate human tissue, collagenase (Type II) digested, and then depleted of CD45-expressing cells by magnetic separation using anti-human CD45 microbeads (Miltenyi, . 10 million CD45-lipoaspirate cells were then resuspended in 50 mL of Matrigel containing 10 mg rhBMP2 (recombinant human BMP2; R&D Systems, Cat#355-BM/CF). The cell solution was then injected subcutaneously into the inguinal fat pads of 8-12-week-old adult NSG immunodeficient mice. One month after transplant, grafts were harvested for histological or FACS analysis as described.
Human adipose stromal cells were harvested and transplanted as above. Local induction with 10 ug rhBMP2 (recombinant human BMP2; R&D Systems, Cat#355-BM/CF) alone or rhBMP2 with rhVEGFR1 (recombinant human VEGFR1; R&D Systems, Cat#321-FL/CF) at a ratio of 3:50 mg allowed for osteo and chondro-induction, respectively. The recombinant proteins were mixed directly with the matrigel and the cell suspension.
Single Cell RNA sequencing (scRNA-seq) Single cell capture and RNA extraction Cells were dissociated into a single cell suspension and prepared for FACS as described under Human Fetal and Adult Bone dissociation and Fluorescence-activated cell sorting (FACS) above. Single cells were sorted into 96-well plates of lysis buffer (1 U/mL RNase inhibitor (Clontech, Cat#2313B), 0.1% Triton (Thermo Fisher Scientific, Cat#85111), 2.5 mM dNTP (Invitrogen, Cat#10297-018), and 2.5 mM oligo dT30VN (IDT, special order) in nuclease-free water (Thermo Fisher Scientific, Cat#10977023)) as described (Picelli et al., 2014) , centrifuged at maximum speed for 30 s at 4 C, snap frozen on dry ice, and then stored at À80 C. ERCC (External RNA Controls Consortium) ExFold RNA Spike-In Mixes (Invitrogen, Cat#4456739)) was added at 1:600,000 dilution to each lysis reaction to be processed in parallel to cellular mRNA. Whole-transcriptome amplification, library preparation, and sequencing Single cell cDNA libraries were constructed using the Smart-seq2 protocol (Picelli et al., 2014) with minor modifications. Briefly, cDNA from single cell RNA was generated by oligo-dT primed reverse transcription with MMLV SMARTScribe reverse transcriptase (Clontech, Cat#639538) and a locked template-switching oligonucleotide (TSO; Exiqon, special order). This was followed by 25 cycles of PCR amplification, which was the optimal number of cycles determined to obtain cDNA concentration of at least 0.05-0.32 ng/mL from each human skeletal lineage cell, using KAPA HiFi hotStart ReadyMix (Kapa Biosystems, Cat#KK2602) and ISPCR primers (IDT; IDT, special order). Amplified cDNA was then purified using 0.6x volume Agencourt AMPure XP beads (BEECKMAN COULTER, Cat#A63882) to remove oligos smaller than 500 base pairs (bp). The resulting cDNA concentration and size distribution for each well was determined on a capillary electrophoresis-based fragment analyzer (Advanced Analytical). Based on this analysis, the cDNA concentration was then normalized to a desirable concentration range of 0.05-0.32 ng/mL by diluting the amplified cDNA from each well. The cDNA was tagmented, uniquely barcoded, and PCR enriched using the Nextera XT DNA Library Prep kit (Illumina, Cat#FC-131-1096) . Libraries were then pooled and purified to remove fragments smaller than $400 bp using 0.6x volume Agencourt AMPure XP beads. Pooled libraries were quantified by Bioanalyzer (Agilent), using High Sensitivity DNA analysis kit, and fluorometrically, using Qubit dsDNA HS Assay kits and a Qubit 2.0 Fluorometer (Invitrogen), and the final concentration was adjusted to 2 nM. The pooled libraries were then sequenced on NextSeq 500** (Illumina) to obtain 2x151 bp paired-end reads at a depth of 1-4.5 3 10 6 reads/cell. **Pooled libraries were initially sequenced on HiSeq 4000 (Illumina); however, due to presence of significant amount of indexswitching (Sinha et al., 2017) in our data, library pools were rerun on the NextSeq 500.
Transcriptional Expression Profiling by microarray mRNA isolation and microarray We performed microarray analyses on highly purified, double-sorted populations of e17.5 mouse and 19-week human SSCs. 10-30,000 cells were directly sorted into 1 mL TRIzol LS (Invitrogen, Cat#10296028). RNA was isolated with RNeasy Micro Kit (QIAGEN, Cat#74004) as per manufacturer's instructions. RNA was twice amplified with an Arcturus RiboAmp PLUS Kit (Applied Biosystems, Cat#KIT0521). Amplified cRNA was streptavidin-labeled, fragmented, and hybridized to Affymetrix arrays 430-2.0 (for mouse genome; Applied Biosystems, Cat#900495), and HG-U133+ (for human genome; Applied Biosystems, Cat#901569). Arrays were scanned with a Gene Chip Scanner 3000 (Affymetrix) running GCOS 1.1.1 software.
Histology
Dissected specimens were fixed in 2% PFA at 4 C overnight. Specimens were decalcified in 400 mM Ethylenediaminetetraacetic acid (EDTA; Invitrogen, Cat#15573-038) in PBS (pH 7.2) at 4 C for 2 weeks with a change of EDTA once at 1 week. The specimens were then dehydrated in 30% sucrose at 4 C overnight. Specimens were embedded in Optimal Cutting Temperature compound (OCT) and sectioned at 5 mm. Representative sections were stained with freshly prepared Hematoxylin (Sigma-Aldrich, Cat#MHS32-1L) and Eosin (Eosin Y; Thermo Fisher Scientific Shandon, Cat#6766009), Movat pentachrome, or Alizarin Red (Sigma-Aldrich, Cat#A5533) stains depending on the individual experiment. For zone demarcation in the growth plate and diaphysis, live bones were bissected along the longitudinal axis of the bone and stained directly with Hoechst (Thermo Fisher Scientific, Cat#62249) and Calcein-AM (Invitrogen, Cat#C1430) intravital dyes as per standard protocols.
Cell culture
Skeletal progenitors were cultured in MEM-alpha medium with 10% human platelet-derived lysate (Stem Cell Technologies, Cat#06960), 1% Penicillin-Streptomycin solution (Pen-Strep; Thermo Fisher Scientific, Cat#15140-122) in an incubator maintained at 37 C with 5% CO 2 . Culture vessels were first coated with 0.1% Gelatin (Millipore, . Cultured cells were lifted for analysis or passaging by incubating with 3000 U/mL type II collagenase in M199 (Sigma-Aldrich, #C6885).
For human colony forming assays, single cells were sorted into each well of a 96-well plate and cultured for 2 weeks. At this time, specimens were examined under a phase microscopy and a cloning ring was used for quantification. The cells were subsequently lifted for staining and analysis by FACS.
Adipogenic Differentiation
Populations of hSSC, hBCSP, hCP and hOP were prospectively isolated using FACS. Cells were seeded at a predetermined uniform density depending on typical cell yield from the specimen. The cell populations were subjected to adipogenic differentiation as described earlier (Ge et al., 2016) . Briefly, cells cultured in proliferation media (DMEM/F12 (Thermo Fisher Scientific, Cat#11320-033), 20% FBS, 1% Pen-Strep) for a couple of passages. After expansion, the cells were plated to confluency and changed to induction media (DMEM/F12, 10% FBS, 1% Pen-Strep, 1 mM dexamethasone (MP Biomedicals, Cat#194561), 58 mg/mL insulin (Human Insulin Recombinant Protein; Invitrogen, Cat#RP-10908), 0.5 mM 3-isobutyl-1-methylxanthine (IBMX; Sigma-Aldrich, Cat#I7018), 200 mM indomethacin (Sigma-Aldrich, Cat#57413), and fed with fresh induction media every third day. Cells were then stained with Oil Red O (Sigma-Aldrich, Cat#O0625) to assess adipogenic potential after 1 week of differentiation.
Osteogenic Differentiation
Populations isolated by FACS were seeded and grown in vitro until 100% confluency, at which point the cell populations underwent osteogenic differentiation. Cells were fed with fresh osteogenic differentiation media (ODM) (MEM-alpha medium [Thermo Fisher, Scientific, Cat#12561-056], 10% FBS, 1% Pen-Strep, 100 nM dexamethasone, 10 mM sodium b-glycerophosphate [Sigma-Aldrich, Cat#G9891], 2.5 mM ascorbic acid 2-phosphate [Sigma-Aldrich, Cat#A8960]) every 3 days for 10 days. Cells were then stained with Alizarin Red (Sigma-Aldrich, Cat#A5533) to assess osteogenic potential.
Chondrogenic differentiation
Cells were cultured as a micro-mass and differentiated using StemPro chondrogenesis differentiation kit (Thermo Fisher Scientific, Cat#A1007101). Cells were resuspended at a cell-density of 1.6x10 7 cells/mL. A 5 mL droplet of the cell suspension was seeded under high humidity conditions in a 24-well plate for 2 hr. After 2 hr, warmed chondrogenic differentiation media was added to the culture vessel. The growing micro-mass was fed with fresh chondrogenesis media every other day in a 37 C incubator with 5% CO 2 . At day 14 the micro mass was fixed, sectioned, and stained with Alcian blue (Sigma-Aldrich, Cat#A5268).
hSSC differentiation from induced pluripotent stem cell (iPSC) Human iPSCs were plated onto Geltrex (GIBCO, Cat#A1569601)-coated dishes in Essential 8 Medium (GIBCO, Cat#A1007101) and cultured in an incubator maintained at 37 C with 5% CO 2 . iPSCs were fed daily with fresh media and maintained at % 80% confluency. Cells were passaged 1:10 using 0.05 mM EDTA. To induce bone formation, iPSCs were differentiated when they reached 80% confluency by switching the cells over to ODM composed of MEM-alpha medium supplemented with 100 nM of dexamethasone, 10 mM b-Glycerophosphate, 2.5 mM ascorbic acid 2-phosphate, and 50 ng/mL of rhBMP2. Differentiating cells were fed with fresh ODM every other day and harvested on week 2 for FACS analysis.
HSC-stromal co-culture and transplant To establish stromal monolayers for hHSC co-culture experiments, human stromal subsets, hSSCs, hBCSPs, and hOPs, were isolated by FACS and cultured as described under Fluorescence-activated cell sorting (FACS) and Cell Culture above. Human HSCs were enriched from freshly processed cord-blood samples by magnetic separation using CD34 microbeads (Miltenyi Biotec, , according to the manufacturer's instructions. CD34+CD38-Lin-HSPC subpopulations (purity > 95%) were isolated for co-culture with SSC-derived stromal populations. CD34+CD38-Lin-HSPC were sorted using a previously established panel that included anti-human lineage markers [CD2 (Cat#555328), CD3 (Cat#555341), CD4 (Cat#555348), CD7 (Cat#555362), CD8 (Cat#555368), CD11b (Cat#555389), CD14 (Cat#562692), CD16 (Cat#555408), CD19 (Cat#555414), CD20 (Cat#561761), CD56 (Cat#555517), all PE-Cy5; all dilution 1:50], CD235a(GPA)-PE-Cy5 (dilution 1:100; BD Biosciences, Cat#559944). Additionally, the following antibodies were used: CD38-PE-Cy7 (dilution 1:50; Cat#33579), CD90-FITC (dilution 1:25; Cat#555595), CD123-PE (dilution 1:10, Cat#554529), CD34-APC (dilution 1:25; Cat#659123)-all from BD Biosciences, CD10-APC-Cy7 (dilution 1:10; Cat#312212), and CD45RA-BV605 (dilution 1:20; Cat#304133)-both from Biolegend. Live cells assessed by negative staining for propidium-iodide (PI, Sigma-Aldrich, Cat#P4170; final concentration: 1 mg/ml) were double sorted. 5000
Lin-CD34+CD38-THY1 lo CD45RA-human cord blood HSCs were then co-cultured with or without confluent human stromal subsets for 14 days in Stemline serum-free hematopoietic stem cell expansion media (Sigma-Aldrich, Cat#S0192) supplemented with 10 ng/mL human recombinant stem cell factor (Peprotech, Cat#300-07), 5 ng/mL human recombinant thrombopoietin (Peprotech, Cat#300-18), 20 ng/mL human basic fibroblast growth factor (R&D Systems, Cat#P09038), and 25 ng/mL human insulin growth factor (R&D Systems, Cat#P05019). After 14-day co-culture, hHSCs were retro-orbitally injected into 6-8-week-old immunodeficient NSG mice conditioned using sub-lethal irradiation (250 rad in single dose) as described earlier (Reinisch et al., 2015) . 8 weeks after transplant, bone marrow aspirates were obtained from recipient mice and analyzed by FACS for expression of human hematopoietic markers, HLA-ABC (pan-human; BioLegend, Cat#311404), hCD45 (pan-hematopoietic; BioLegend, Cat#103258), hCD19 (B lymphoid cells; BioLegend, Cat#302226) , and hCD33 (myeloid cells; BioLegend, Cat#366626).
Lentiviral transduction of mSSCs
Fetal mSSCs were resuspended in MEM-alpha medium with 15% Fetal Calf Serum (FCS) and transduced individually with lentivirus carrying GFP, RFP, CFP, GFP/SOST, or GFP/DNAJB6 cDNA expression-cassettes. 48 hr after transduction, cells were sorted for GFP expression and transplanted as described above.
ATAC-seq
Cells for ATAC-seq were sorted as described above. The Fast-ATAC version of the ATAC-seq protocol was performed as described (Corces et al., 2016) . Briefly, 10,000 cells per replicate (2 replicates per cell type) were resuspended in transposase reaction mixture (25 mL of 2X Tagmentation DNA Buffer [TD buffer; Illumina, Cat#FC-121-1030], 2.5 mL Tn5 enzyme [Illumina, Cat#FC-121-1030] , 0.5 mL 1% digitonin [Promega Cat#G9441], and 22 mL water), incubated for 30 min at 37 C. The tagged and transposed DNA fragments were purified using MinElute Reaction Cleanup kit (QIAgen, Cat#28204) and eluted in 11 mL elution buffer (from the MinElute kit) and amplified as described (Buenrostro et al., 2013) . Libraries were sequenced to a depth of 12-23 million reads per replicate.
QUANTIFICATION AND STATISTICAL ANALYSIS
Fluorescence-activated cell sorting (FACS) Flow cytometry was performed on FACS Aria II (BD Biosciences). Gating schemes were established with fluorescence-minus-one (FMO: staining with all fluorophores except one) controls and negative PI staining (1 mg/ml) was used as a measure for cell viability. Cells from the human xenograft model and from the in vivo skeletal-induction assays were also analyzed by FACS. FlowJo was used to analyze FACS data.
Transcriptional Expression Profiling
Raw microarray data were submitted to Gene Expression Commons (https://gexc.riken.jp) (Seita et al., 2012) , where data normalization was computed against the Common Reference, which is a large collection of more than 11,939 mouse and 25,229 human array experiments deposited to the National Institutes of Health Gene Expression Omnibus (NIH GEO) database. GEXC assigns a threshold value to each probeset using the StepMiner algorithm (Sahoo et al., 2007) and calculates a percentile value between À100% and +100% for each available gene, allowing us to compare mouse and human gene expression on a normalized, continuous scale. Meta-analysis of the Common Reference also provides the dynamic range of each probe set on the array, and, in situations where there are multiple probe sets for the same gene, the probe set with the widest dynamic range was used for analysis. The Affymetrix Mouse Genome 430 2.0 Array includes 45,101 probe sets, of which 17,872 annotated genes are measurable. A list of mSSC/mBCSPspecific genes was generated by using the pattern search feature of the Gene Expression Commons (GEXC) database (Seita et al., 2012) for transcripts expressed in SSCs and BCSPs but not in their downstream progeny (Table S1 ). The biomaRt R package (Durinck et al., 2009 ) was used to determine human orthologs to the mSSC/mBCSP-specific genes. Single cell RNA-seq data from each growth plate zone and diaphyseal region were then queried for expression of these human orthologs and zero-mean normalized by subtracting the mean gene expression. Percent positive gene enrichment was calculated by dividing the total number of positively expressed genes by the total number of genes queried for each cell. Heatmap in Figure 1E was generated by plotting the most variable genes across single cells in the growth plate zones and diaphyseal region.
Scatterplots comparing mouse and human gene expression were plotted using ggplot2-a package for data visualization within the R statistical computing environment (R Development Core Team, 2017) . Normalized gene expression values from probe sets with the widest dynamic range were plotted for a curated list of canonical signaling and bone development genes. Genes were broken into four quadrant groups: Q1: YMouse [Human, Q2: [Mouse [Human, Q3: YMouse YHuman, Q4: [Mouse YHuman; percent of each pathway represented in each quadrant was calculated as:
Number of pathway genes in quadrant Total number of pathway genes . Heatmaps were generated using normalized expression values from GEXC (Seita et al., 2012) .
Single-cell RNA-seq Data processing bcl2fastq2 2.18 (Illumina) was used to extract the data and generate FASTQ files for each single cell by using unique barcode combinations from the Nextera XT preparation. Raw reads were trimmed for base call quality (PHRED score > = 21) and for adaptor sequences using Skewer (Jiang et al., 2014) . Trimmed reads were then aligned to hg38 using STAR 2.4 (Dobin et al., 2013) , and transcripts per million (TPM) was calculated using RSEM 1.2.21 (Li and Dewey, 2011). Raw TPM values were mean-and log2-normalized. Cells with less than 200,000 uniquely mapped reads or fewer than 1,000 genes detected were excluded, leaving 1308 out of 1508 total cells for downstream analysis. Genes that were undetectable across all cells were also removed, leaving 21,414 genes out of total 26,856. Additional filtering criteria are described here for each figure.
Data analysis
Unsupervised principal component analysis (PCA) of single cells from fetal, adult, B-HAS-derived, and iPSC-derived hSSCs was completed using the prcomp() R function (R Development Core Team, 2011) . Quality filtering prior to entering the matrix for PCA included (1) removal of cells with less than 2400 gene features, (2) removal of unexpressed genes and genes in which a single value occupied greater than 80% of the total sum. A total of 196 cells, including fetal (n = 42), adult (n = 36), B-HAS-derived (n = 77), and iPSC-derived hSSCs (n = 41) and 15,386 genes were analyzed. Supervised analysis of our scRNA-seq data was guided by a gene set of canonical signaling pathways and bone development pathways created using Gene Expression Commons (GEXC) database (Seita et al., 2012) and the Molecular Signatures Database (MSigDB) (Liberzon et al., 2015) . Quality filtering steps included (1) removal of cells with fewer than $33% of gene features expressed and (2) removal of genes expressed in fewer than $5% of cells. Gene expression values were log 2 normalized. Total of 114 genes across 196 cells were analyzed. The same [cell x gene] matrix was used to generate a Pearson correlation matrix using the ggcorrplot package in R (Kassambara, 2016) . For the bulk correlation matrix, mean gene expression was calculated for each gene per group (i.e., fetal, adult, B-HAS, iPSC) and analyzed using the ggcorrplot package in R by Pearson's correlation.
ATAC-seq analysis ATAC-seq reads were trimmed using CutAdapt (Martin, 2011) and aligned to the human (hg19) or mouse (mm9) genome using Bowtie2 (Langmead and Salzberg, 2012) . After filtering and removing duplicate reads, peaks were called using MACS2 as previously described, without a shifting model (Buenrostro et al., 2013) . HOMER was used for motif analysis using default settings (Heinz et al., 2010) . Promoter-proximal and promoter-distal peaks were separated based on distance to the nearest TSS (> 2kb, distal. % 2kb, proximal) using HOMER peak annotation. To identify peaks near SSC-specific, human-specific, or mouse-specific genes, we used the HOMER annotatePeaks tool to identify the nearest gene to a given peak. We then took the set of all peaks closest to an SSC-specific, human-specific, or mouse-specific gene and performed motif enrichment analysis. To find individual instances of RUNX2 motifs, we used the HOMER annotatePeaks tool with the ''-motif'' option specifying the RUNX2 consensus motif.
Statistical analysis
Bar chart data illustrating the analyses comparing SSCs in human fracture and xenografts are presented as the mean ± SEM. Analyses were performed on GraphPad Prism. Unpaired, two-tailed Student's t tests were used, with the assumption of unequal variances (Figure 5 ). Reproducibility was confirmed by repeating the analysis on multiple patients, n represents the number of patients.
DATA AND SOFTWARE AVAILABILITY
The accession number for the ATAC-seq, RNA-seq, and microarray data reported in this paper is GEO SRA: PRJNA478935. ACKR3  BMPR1A  CD9  GREM1  ITGAV  MIF  PDIA3  SCUBE1  TMEM8B  ADAM9  BMPR1B  CLIC4  HHIP  JAG1  MMP16  PDIA4  SCUBE3  TNFRSF10B  ADAMTS7 BMPR2  CSPG4  HMGB1  JAM2  MRC2  PDPN  SDC4  TNFRSF12A  ADGRA2  C1QBP  ENG  HSP90AA1 LAMP2  NID2  PPFIA3  SFRP1  TNFSF11  AIMP1  CAV2  ENPEP  HSPA2  LAYN  NLGN2  PRNP  SLC44A1  TNN  AMOT  CD109  ENPP1  HYAL2  LDLR  NLGN4X  PTGFRN  SLIT2  TNS1  APMAP  CD164  ERP44  IGF1R  LGALS1  NOTCH2  PTPRK  SRPX  TRPV4  APP  CD24  F3  IGF2R  LIFR  NRDC  PVR  SRPX2  USP14  ASIC1  CD276  FERMT2  IL13RA1  LPAR1  NT5E  RALA  SULF1  VCAM1  ATP1B3  CD302  FGFR2  IL1R1  LPAR2  PAM  RAMP1  SULF2  VEGFA  AXL  CD320  FGFR3  IL6ST  LPL  PCSK6  RC3H2  TFRC  WNT5A  BACE1  CD47  FURIN  INSR  LRP6  PDGFA  ROBO1  TGFBR3  WNT5B  BACE2  CD59  FUT4  INTU  LRPAP1  PDGFC  ROBO2  THBS1  BGN  CD63  FZD1  ITGA6  MCAM  PDGFRA  RPS6KB1 THY1  BMP2  CD81  GHR  ITGAE  MICA  PDGFRB  SCARA5 NRDC  HSPA2  RC3H2  SULF1  AIMP1  CD81  ADGRA2  C1QBP  PDGFRB  HSP90AA1   USP14  JAG1  INTU  TNS1  ATP1B3  RALA  FUT4  ENG  ITGAE  MCAM  SCUBE1  NLGN4X   LIFR  ADAMTS7  HMGB1  AMOT  SLIT2  VCAM1   PDPN  CD109  SCARA5  GREM1  RAMP1  SCUBE3  SRPX2  TRPV4  SDC4  BMP2  TNFRSF10B  ENPEP  ITGA6  ENPP1  LPAR2  THBS1  TNFRSF12A  PVR  LDLR  LPAR1  WNT5B  NID2  PAM  ACKR3  BMPR1B  MMP16  HHIP  LAYN  SRPX  WNT5A  CSPG4  FGFR2  F3  IL6ST  NT5E  IL13RA1  FERMT2  ROBO1  BACE1  PDGFC  PTGFRN  ROBO2  CD59  PRNP  LRP6  TGFBR3  PPFIA3  BGN  NLGN2  AXL  LRPAP1  TMEM8B  MICA  APP  PCSK6  BMPR1A  HYAL2  VEGFA  FURIN  APMAP  PDGFA  CD63  CD276  SFRP1  PDIA4  LAMP2  PDIA3  NOTCH2  CD164  JAM2  ASIC1  CLIC4  BMPR2  SULF2  PDGFRA  CD24  IGF2R  BACE2  FZD1  CD9  TIMP2  SLC44A1  IL1R1  FGFR3  MIF  CAV2  ITGAV  TFRC  ERP44  INSR  LGALS1  TNFSF11  ADAM9  LPL  CD320  THY1  TNN  MRC2  CD47  CD302  IGF1R  RPS6KB1 A) Experimental strategy to test the self-renewal property of hSSC (n = 6). (B) Prior to the primary transplant in the renal capsule of NSG mice, freshly isolated hSSC were stained with a lipophilic dye (red) and compared to unstained cells (gray). The resulting graft was explanted 2 weeks post-transplant. The hSSC were re-isolated from the graft and exhibited lower lipophilic dye fluorescence (blue) indicating that dye-labeled-hSSCs had undergone cell-division in vivo. The re-isolated hSSCs were then transplanted into renal capsule of a secondary NSG host, allowed to develop in vivo for 4 weeks, and the resulting grafts were extracted for histology. C) (i) 500 single hSSC were isolated from fresh 17-19-week fetal bone, plated for colony formation and imaged by phase microscopy to examine cell morphology after each of the serial passages all the way up to the quaternary colonies (top row). Scale: 20 mm. FACS plots show that throughout serial colony formation, hSSC retains their ability to self-renew and ultimately consists of 49.3% of the parent population after quaternary colony formation (bottom row).
(ii) 100,000 hSSCs isolated in C-(i) were embedded in Matrigel and transplanted into the renal capsule of NSG mice. The primary graft was explanted 4 weeks after development, dissociated, hSSCs were purified and plated for two-rounds of serial colony formation in vitro up to a tertiary passage. Phase microscopic images (legend continued on next page)
